OTCMKTS:RCDTF Recordati Industria Chimica E Farmaceutica Q4 2025 Earnings Results & Report $58.79 0.00 (0.00%) As of 11/13/2026 Recordati Industria Chimica E Farmaceutica beat analyst earnings expectations but missed on revenue in its Q4 2025 results, released March 31, 2026. The company reported EPS of $0.88 versus the $0.8570 consensus estimate, while revenue of $770.90 million fell short of the $778.42 million estimate by $7.52 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ4 2025Report DateMarch 31, 2026TimeBefore Market Opens Recordati Industria Chimica E Farmaceutica EPS ResultsActual EPS$0.88Consensus EPS $0.8570Beat/MissBeat by +$0.0230One Year Ago EPSN/ARecordati Industria Chimica E Farmaceutica Revenue ResultsActual Revenue$770.90 millionExpected Revenue$778.42 millionBeat/MissMissed by -$7.52 millionYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Recordati Industria Chimica E Farmaceutica Q4 2025 Earnings FAQ Did Recordati Industria Chimica E Farmaceutica beat earnings estimates for Q4 2025? Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) reported earnings of $0.88 per share for Q4 2025, beating the consensus estimate of $0.8570. The report was announced on Tuesday, March 31, 2026. What was Recordati Industria Chimica E Farmaceutica's revenue for Q4 2025? Recordati Industria Chimica E Farmaceutica reported revenue of $770.90 million for Q4 2025, against a consensus estimate of $778.42 million. Recordati Industria Chimica E Farmaceutica Earnings HeadlinesRecordati Industria Chimica e Farmaceutica S.p.A.(BIT:REC) dropped from FTSE All-World IndexNovember 13 at 9:39 AM | marketscreener.comMRecordati Industria Chimica E Farmaceutica S.P.A. Confirms Earnings Guidance for the Full Year 2026 and Reaffirms Earnings Guidance for the Fiscal Year 2027November 11, 2026 | marketscreener.comMMy $247 scanner for $7Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.November 16 at 1:00 AM | Profits Run (Ad)Respighi BidCo Raises Recordati Stake Above 74%November 3, 2026 | tipranks.comRecordati (BIT:REC) Stock Could Be 41% Undervalued On Cash FlowOctober 24, 2026 | finance.yahoo.comConsensus price target for Recordati Industria Chimica e Farmaceutica S.p.A - depositary receipt decreases 38.68% to $14.41October 22, 2026 | msn.comSee More Recordati Industria Chimica E Farmaceutica Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Recordati Industria Chimica E Farmaceutica? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Recordati Industria Chimica E Farmaceutica and other key companies, straight to your email. Email Address About Recordati Industria Chimica E FarmaceuticaRecordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) is an Italian pharmaceutical company founded in 1926 and headquartered in Milan. It develops, manufactures and commercializes medicines, with businesses spanning specialty and primary-care treatments as well as medicines for rare diseases. Its products address a range of therapeutic areas, including endocrinology, urology, cardiovascular medicine and other specialist fields. Through its rare-disease business, Recordati also provides treatments for patients with uncommon and complex conditions. The company serves markets in Europe and other regions worldwide, selling its medicines through its own commercial operations and partners. Its international business has expanded over time through acquisitions, including the addition of EUSA Pharma, which strengthened its rare-disease portfolio.View Recordati Industria Chimica E Farmaceutica ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles 3 Building-Materials Stocks Rallying While Homebuilders Struggle to Find BuyersMarketBeat Week in Review – 11/9 - 11/133 AI Hardware Leaders Are Raising Dividends, But Which Offers More Income?Nu Holdings Earnings Show a Compounder Priced Like a Brazil BetCould Big Buybacks Be the Next Catalyst for These 3 AI Stocks?Cerebras Q3 Results: How Much More Proof Does Wall Street Need?Sandisk's Sell-Off May Be Losing Steam, But the Biggest Risk Still Looms Upcoming Earnings Walt Disney (11/17/2026)Home Depot (11/17/2026)NVIDIA (11/17/2026)Lowe's Companies (11/18/2026)TJX Companies (11/18/2026)Target (11/18/2026)Palo Alto Networks (11/18/2026)NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.